Collaborating Across the Alliance
Nanotechnology research is an interdisciplinary endeavor by nature. Investigators with basic science, engineering, molecular biology, and clinical backgrounds must collaborate in order to design new drugs and diagnostic tools that can improve patient outcomes.
The NCI Alliance for Nanotechnology in Cancer has put the tools and resources in place to help investigators explore and capitalize on opportunities to collaborate with researchers across the Alliance and beyond. This collaboration has already led to the rapid development of novel and innovative nanoscale technologies that are providing meaningful advances in cancer detection, diagnosis, and treatment.
Explore how the Alliance encourages and fosters collaboration across scientific disciplines and how you can participate through the resources below.
Working with the NCI
Participate in other collaborative efforts underway across the NCI that are focused on nanotechnology and cancer research. Explore opportunities in nanotechnology across the NCI »
Translation of Nanotechnology in Cancer
NCI has initiated a public-private industry partnership focused on Translation of Nanotechnology in Cancer (TONIC), to promote translational research and development opportunities of nanotechnology-based cancer solutions. Learn more about TONIC and how to get involved »